Therapeutic area

Dermatology

Chronic inflammatory skin conditions, keratinization disorders, and immune-mediated dermatoses.

Core & active disease programs

Atopic Dermatitis

$207.8B attributable cost

$23.2B$ drug spend

89 assets · 1 indication

$87.4B+ attributable cost

70 assets · 2 indications

Provisional & emerging programs (11)Early clinical pipeline & single-asset indications

Hidradenitis Suppurativa

Alopecia Areata

Chronic Spontaneous Urticaria

Prurigo Nodularis

Cutaneous Lupus Erythematosus

Cutaneous Sarcoidosis

Lichen Planopilaris

Necrobiosis Lipoidica

Seborrheic Dermatitis

All assets in Dermatology